en 
fr 
de 
es 
ru 
pt 
ar 
The ORF1ab and N gene sequences of SARS-CoV-2 are used as target sequences and the human RNaseP gene is used as internal control. For this test kit, a specific primer and a fluorescence probe are designed. Reverse transcriptase, RNA enzyme inhibitor, DNA polymerase and four deoxynucleotide monomers are formulated. By employing the polymerase chain reaction (PCR) and fluorescence probe techniques, the one-step method is used to rapidly qualitatively test if the corresponding ORF1ab and N genes exist in the clinical sample.
Please note: this product is currently not authorized for sale or distribution in the U.S. It's strictly forbidden to advertise, marketing and resell to any U.S. customers or U.S. territories.
SARS-CoV-2 Nucleic Acid Test Kit is a real-time PCR test intended for the qualitative detection in ORF1ab and N genes of SARS-CoV-2 viral nucleic acids in pharyngeal specimens (oropharyngeal swabs, nasopharyngeal swabs) from individuals who are suspected of COVID-19 by their healthcare provider.
Step 1 Nucleic Acid Extraction
Step 2 RT-PCR Amplification and Analysis
| Number of Test / Kit | 24 tests |
| Sample Type | Oropharyngeal swabs, Nasopharyngeal swabs |
| Acceptable Real-time PCR System | LEPU Lepgen-96, Roche LightCycler 480 series Bio-Rad CFX96 |
| Reagent Preparation Condition | 4 weeks at 2℃ ~8℃ |
| Reagent Storage Condition | 6 months at -25℃ ~ -15℃, The freeze/thaw cycles should not exceed five times |
Component | Qty. | Volume | Ingredients |
Cov-PCR Reaction Liquid | 1 | 460μl/vial | ORF1ab and N genes primer and probe, Internal control RNase P gene primer and probe, Deoxyribonucleoside triphosphate |
Cov-enzyme | 1 | 24μl/vial | DNA polymerase, Reverse transcriptase, Recombinant RNase inhibitor. |
Cov-Negative Control | 1 | 420μl/vial | DEPC treated water |
Cov-Positive Control | 1 | 420μl/vial | ORF1ab and N genes, RNase P gene armored RNA solution |
| Catalogue No. | SARS-CoV-2 Nucleic Acid Test Kit |
| (PCR-Fluorescence Probe Method) |
Email Us: 
